Dr. Rüdiger Schulz-Wendtland[email protected]Clinical NewsStereotactic breast biopsies: Room for improvement?When it comes to the business side of radiology, there is considerable scope for improvement, according to Dr. Rüdiger Schulz-Wendtland. Using breast biopsies as an example, he explains how delays and inefficiencies can have a substantial effect on a hospital's bottom line.January 23, 2017Page 1 of 1Top StoriesMolecular ImagingWill FAP-targeted theranostics live up to their promise?Fibroblast activation protein (FAP)-targeted theranostics is an emerging technique in the battle against cancer.CTNew evidence emerges on U.K. radiology’s workforce crisisArtificial IntelligenceBarcelona radiomics team reveals AI progress in liver cancerArtificial IntelligenceMomentum builds for AI use in intracranial hemorrhage casesSponsor ContentJoin us on 17 June for a webinar
